共 46 条
- [41] ELISA FOR HERPES-SIMPLEX VIRUS (HSV) TYPE-SPECIFIC ANTIBODIES IN HUMAN-SERA USING HSV TYPE-1 AND TYPE-2 POLYSPECIFIC ANTIGENS BLOCKED WITH TYPE-HETEROLOGOUS RABBIT ANTIBODIES ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA SECTION B-MICROBIOLOGY, 1979, 87 (04): : 261 - 263
- [42] PREVALENCE AND CYTOLOGIC MANIFESTATIONS OF HUMAN PAPILLOMA-VIRUS (HPV) TYPE-6, TYPE-11, TYPE-16, TYPE-18, TYPE-31, TYPE-33, TYPE-35, TYPE-42, TYPE-43, TYPE-44, TYPE-45, TYPE-51, TYPE-52, AND TYPE-56 AMONG 500 CONSECUTIVE WOMEN INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1992, 11 (03) : 197 - 203
- [45] Type-specific epitopes targeted by monoclonal antibodies with exceptionally potent neutralizing activities for selected strains of human immunodeficiency virus type 1 map to a common region of the V2 domain of gp120 and differ only at single positions from the clade B consensus sequence JOURNAL OF VIROLOGY, 2007, 81 (03) : 1424 - 1432
- [46] Human Papilloma Virus-Type 16 (HPV-16) & Human Herpes Virus-Type 8 (HHV-8) infections were found to be co-existing major cancer-contributing factors. Individualized, safe, effective treatment of hopelessly advanced cancer patients with metastasis by combining 4 methods of effective treatment: 1) Optimal dose of Vitamin D3 using its 10 unique beneficial effects, 2) Selective Drug Uptake Enhancement Method, 3) Stimulation of newly discovered Thymus gland representation areas on the back of each hand, & 4) Identification & removal of co-existing cancer-contributing factors ACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH, 2018, 43 (2-3) : 119 - 157